
M.D. | Resident Physician, Internal Medicine🇺🇸 @InfirmaryHealth | Aspiring Cardiologist🫀| Cinema Buff🍿| Marvel Fan | Tennis🎾| #CardioX #MedTwitter
- Tweets2.4K
- Following1.8K
- Followers304
- Likes2.9K

ALT A table showing the clinical end points at 1 year (intention-to-treat analysis). It compares two groups: Ticagrelor-Policy Group (9444 patients) and Prasugrel-Policy Group (7651 patients). Primary end point shows 1113 events in the Ticagrelor-Policy Group and 848 in the Prasugrel-Policy Group. Secondary end points are listed, including death from any cause, myocardial infarction, stroke, major bleeding, and stent thrombosis, with corresponding patient numbers and percentages for each group. Odds ratios with confidence intervals are provided.

ALT A table titled "AHA Scientific Sessions 2026 — Late-Breaking Science I-VI" in Chicago, IL, from November 6-9, 2026. The table has four columns: Trial Acronym, Title, Topics of Focus, and Results. The table includes various studies related to cardiovascular topics with acronyms and brief descriptions. AHA logo is visible at the top.

ALT This image contains an excerpt from the Research Summary "Targeted Use of CT Coronary Angiography in Acute Chest Pain" published in the New England Journal of Medicine. It includes participant statistics with 3,170 adults; median age 61; 70% men and 30% women. Illustrations depict a person experiencing chest pain and different care methods with figures: 1,587 for CT Coronary Angiography-Guided Care and 1,583 for Standard Care. A prompt to read the full Research Summary at NEJM.org sits at the bottom.

ALT A graph from the Original Article "Left Bundle-Branch Pacing versus Right Ventricular Pacing for Atrioventricular Block.” The trial name, OptimPacing, is in parentheses after the title. The graph shows the primary outcome. The trial results are being presented at the American Heart Association Scientific Sessions 2026. The logo of the New England Journal of Medicine is at the bottom.































